Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed
This study has been completed.
Study NCT00170469   Information provided by PharmAthene UK Limited
First Received: September 9, 2005   Last Updated: September 12, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bacillus Anthracis (Anthrax)
Additional conditions recognized in this trial
Anthrax
More general conditions related to this trial
Bacillaceae Infections
Bacterial Infections
Gram-Positive Bacterial Infections
Interventions listed in this trial
AVA
rPA vaccine containing alhydrogel
Additional drug interventions recognized in this trial
Aluminum Hydroxide
More general drug interventions related to this trial
Adjuvants, Immunologic
Antacids
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
PharmAthene UK Limited
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services